Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Feasibility of Community Occupational Therapy for Dementia (COT-D) (COT-D)

4. November 2026 aktualisiert von: University of Vic - Central University of Catalonia

Feasibility and Acceptability of Community-Based Occupational Therapy for People Living With Dementia

The goal of this feasibility pilot clinical trial is to evaluate the feasibility and acceptability of a community-based occupational therapy protocol for people living with dementia in community settings. The protocol was developed through a systematic review of occupational therapy interventions and a modified Delphi study to establish expert consensus regarding its therapeutic components and characteristics.

The main questions it aims to answer are:

  • Is the community-based occupational therapy protocol feasible to implement for people living with dementia in community settings?
  • Is the intervention acceptable to participants and their caregivers?
  • Can the study procedures be successfully implemented to inform the design of future clinical trials?

Participants will:

  • Receive the community-based occupational therapy intervention delivered according to the study protocol.
  • Participate in study assessments throughout the intervention period.
  • Provide information that will help researchers evaluate the feasibility and acceptability of the intervention and study procedures.

This study will also provide preliminary information about potential changes in occupational outcomes following participation in the intervention.

The results of this pilot study will help optimize the intervention protocol and inform the design of future clinical trials evaluating its effectiveness in people living with dementia. In addition to quantitative outcome measures, participants' and caregivers' experiences of the intervention and study procedures will be collected to further evaluate intervention acceptability and identify potential barriers, facilitators, and areas for protocol refinement.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Detaillierte Beschreibung

People living with dementia frequently experience progressive changes that affect their ability to participate in meaningful daily activities and maintain occupational performance while living in the community. Occupational therapy interventions may support meaningful participation in everyday life by addressing the individual needs, preferences, abilities, and environmental contexts of people living with dementia and their caregivers. Current evidence suggests that person-centered and occupation-based occupational therapy interventions may contribute to promoting occupational performance, participation, and quality of life among adults living with dementia (Smallfield et al., 2024).

However, occupational therapy interventions for people living with dementia are characterized by considerable heterogeneity regarding their therapeutic components, delivery methods, intervention intensity, care settings, and outcome measures. Existing evidence includes interventions delivered across community and residential settings that differ substantially in their characteristics and objectives, highlighting the need for evidence-informed intervention protocols that can be systematically developed and evaluated before their implementation in clinical practice (Uceda-Portillo et al., 2024).

The community-based occupational therapy protocol evaluated in this study was developed as part of a doctoral research project aimed at promoting meaningful participation among people living with dementia living in community settings. The development of the intervention protocol followed a sequential methodological process designed to ensure that the intervention is informed by current scientific evidence and expert consensus before evaluating its implementation in clinical practice.

This process included a systematic review of occupational therapy interventions for people living with dementia and a modified Delphi study involving a multidisciplinary panel of experts to establish consensus regarding the characteristics of the intervention protocol. The present study represents the next stage of this research process by evaluating the feasibility and acceptability of implementing the intervention protocol in community settings.

Community-based occupational therapy interventions for people living with dementia constitute complex interventions that require careful evaluation before undertaking larger clinical trials (Skivington et al., 2021). Feasibility pilot studies provide essential information regarding the implementation of interventions and study procedures and contribute to the planning, refinement, and optimization of future effectiveness studies (Eldridge et al., 2016).

Previous pilot studies evaluating occupational therapy interventions in people living with dementia have highlighted the importance of examining the applicability, implementation, and acceptability of interventions before their wider adoption in clinical practice (Pozzi et al., 2019).

This feasibility pilot clinical trial will provide information regarding the feasibility and acceptability of implementing the intervention protocol in community settings. In addition, the study will provide preliminary information about potential changes in occupational outcomes following participation in the intervention. These findings are intended to inform the refinement of the intervention protocol and contribute to the planning of future clinical trials rather than to establish the clinical effectiveness of the intervention.

The primary objectives of this feasibility pilot clinical trial are to:

  • Evaluate the feasibility of implementing the community-based occupational therapy intervention in community settings for people living with dementia.
  • Evaluate the acceptability of the intervention and study procedures among participants and their caregivers.
  • Determine whether the proposed study procedures can be successfully implemented to support the design of future clinical trials.

This study will also provide preliminary information about potential changes in occupational outcomes following participation in the intervention, including occupational performance, participation in meaningful daily activities, and satisfaction with occupational performance.

The findings of this feasibility pilot clinical trial will contribute to the refinement and optimization of the intervention protocol and provide essential information for planning future clinical trials evaluating its clinical effectiveness. Finally, this study aims to support the development of evidence-informed, person-centered, and community-based occupational therapy interventions for people living with dementia and facilitate their future translation into clinical practice.

The results of this pilot study will help optimize the intervention protocol and inform the design of future clinical trials evaluating its effectiveness in people living with dementia. In addition to quantitative outcome measures, participants' and caregivers' experiences of the intervention and study procedures will be collected to further evaluate intervention acceptability and identify potential barriers, facilitators, and areas for protocol refinement.

Studientyp

Interventionell

Einschreibung (Geschätzt)

48

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

    • La Rioja
      • Logroño, La Rioja, Spanien, 26003
        • Asociación de Familiares de Enfermos de Alzheimer de la Rioja
        • Kontakt:

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Kind
  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria for People Living With Dementia:

  • Clinical diagnosis of dementia.
  • Mild to moderate dementia, corresponding to Global Deterioration Scale stages 4 or 5.
  • Living in the community and not residing in a long-term care facility.
  • Able to participate in individual and group sessions lasting approximately 45 to 60 minutes.
  • Able to attend the community-based sessions with available support when needed.
  • Able to provide informed consent or having a legally authorized representative who can provide consent in accordance with applicable regulations.
  • Having a primary caregiver who meets the caregiver eligibility criteria.

Inclusion Criteria for Caregivers:

  • Age 18 years or older.
  • Identified as the primary caregiver of the participating person with dementia.
  • Provides regular assistance or support in everyday life.
  • Willing to participate in study assessments and the caregiver components of the intervention.
  • Able to provide informed consent.

Exclusion Criteria for People Living with Dementia:

  • Severe behavioral or psychological symptoms that prevent safe participation.
  • Acute or unstable medical or psychiatric condition that may interfere with participation.
  • Severe uncorrected sensory or communication impairment that prevents participation despite reasonable accommodations.
  • Concurrent participation in another intervention study likely to affect the study outcomes.
  • Inability of the participant to complete the essential study procedures.

Exclusion Criteria for Caregivers:

- Inability to complete the essential study procedures required by the intervention or assessment protocol.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Versorgungsforschung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Community-Based Occupational Therapy Intervention

Participants assigned to this arm will receive the community-based occupational therapy intervention delivered according to the study protocol. The intervention is person-centered and combines individual and group-based components designed to promote meaningful participation in everyday life among community-dwelling people living with dementia and their caregivers. The intervention will be delivered in community settings by occupational therapists following standardized study procedures.

The community-based occupational therapy intervention is a person-centered and occupation-based program designed for community-dwelling people living with dementia and their caregivers. The intervention is delivered over approximately 8 to 10 weeks and combines individual and group-based components implemented in community settings according to a standardized study protocol. Participants receive between 10 and 14 intervention sessions, including individual sessions involving the person with dementia and their caregiver and group sessions designed to promote meaningful participation in everyday life. Caregivers also participate in group sessions addressing their needs within the intervention framework. All intervention components are delivered by occupational therapists following standardized study procedures.

Kein Eingriff: Usual Care

Participants assigned to this arm will continue to receive their usual health and social care services available in the community during the study period. No additional occupational therapy intervention associated with the study protocol will be provided.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Recruitment and retention
Zeitfenster: From enrollment to completion of post-intervention assessments (approximately 8-10 weeks).

Recruitment will be assessed as the number and proportion of eligible participants who consent to participate in the study. Retention will be assessed as the number and proportion of participants who complete the intervention and post-intervention assessments. Furthermore, feasibility will be evaluated using the Feasibility of Intervention Measure (FIM), a 4-item measure rated on a 5-point scale from 1 (completely disagree) to 5 (completely agree). The score is the mean of the four items and ranges from 1 to 5, with higher scores indicating greater perceived feasibility.

From enrollment to completion of post-intervention assessments (approximately 8-10 weeks).
Adherence
Zeitfenster: Throughout the intervention period (approximately 8-10 weeks).

Intervention adherence will be assessed by participant attendance and completion of the intervention components delivered according to the study protocol.

Throughout the intervention period (approximately 8-10 weeks).
Acceptability
Zeitfenster: Post-intervention (approximately 8-10 weeks).

Intervention acceptability will be evaluated among participants and caregivers following completion of the intervention using qualitative feedback regarding their experiences with the intervention and study procedures, including perceived benefits, barriers to participation, and suggestions for improvement. Furthermore, acceptability will be evaluated using the Acceptability of Intervention Measure (AIM), a 4-item measure rated on a 5-point scale from 1 (completely disagree) to 5 (completely agree). The score is the mean of the four items and ranges from 1 to 5, with higher scores indicating greater perceived acceptability.

Post-intervention (approximately 8-10 weeks).
Protocol Implementation
Zeitfenster: Throughout the intervention period (approximately 8-10 weeks).

The implementation of the intervention protocol will be assessed by documenting the successful delivery of the planned intervention components and recording any deviations from the study protocol throughout the study period.

Throughout the intervention period (approximately 8-10 weeks).

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Meaningful Participation (Engagement in Meaningful Activities Survey)
Zeitfenster: Baseline, post-intervention (approximately 8-10 weeks), and one-month follow-up.

Meaningful participation will be assessed using the Engagement in Meaningful Activities Survey (EMAS). The EMAS evaluates the extent to which individuals perceive their daily activities as meaningful, personally valued, and consistent with their sense of competence, identity, and purpose in everyday life. The EMAS consists of 12 items rated on a 5-point scale from 1 (never) to 5 (always). The total score ranges from 12 to 60, with higher scores indicating greater engagement in meaningful activities.

Baseline, post-intervention (approximately 8-10 weeks), and one-month follow-up.
Occupational Performance (Canadian Occupational Performance Measure)
Zeitfenster: Baseline, post-intervention (approximately 8-10 weeks), and one-month follow-up.

Occupational performance will be assessed using the performance score of the Canadian Occupational Performance Measure (COPM). The COPM is a person-centered and occupation-based measure that evaluates participants' perceived performance in individually identified meaningful occupations. Performance is rated from 1 (not able to do it at all) to 10 (able to do it extremely well) for each identified occupational problem, and the score is the mean across problems, with higher scores indicating better perceived performance.

Baseline, post-intervention (approximately 8-10 weeks), and one-month follow-up.
Satisfaction With Occupational Performance (Canadian Occupational Performance Measure)
Zeitfenster: Baseline, post-intervention (approximately 8-10 weeks), and one-month follow-up.

Satisfaction with occupational performance will be assessed using the satisfaction score of the Canadian Occupational Performance Measure (COPM). The COPM evaluates participants' satisfaction with their performance in individually identified meaningful occupations. Satisfaction is rated from 1 (not satisfied at all) to 10 (extremely satisfied) for each identified problem, and the score is the mean across problems, with higher scores indicating greater satisfaction.

Baseline, post-intervention (approximately 8-10 weeks), and one-month follow-up.
Caregiver's Sense of Competence (Short Sense of Competence Questionnaire)
Zeitfenster: Baseline, post-intervention (approximately 8-10 weeks), and one-month follow-up.

Caregiver's sense of competence will be assessed using the Short Sense of Competence Questionnaire (S-SCQ). The S-SCQ is a 7-item questionnaire that evaluates caregivers' perceived competence in dealing with the burden of caregiving for a person with dementia. Each item is rated on a 5-point Likert-type scale from 1 (completely agree) to 5 (completely disagree). The total score ranges from 7 to 35, with higher scores indicating a greater sense of competence.

Baseline, post-intervention (approximately 8-10 weeks), and one-month follow-up.
Caregiver-rated Functional Dependence and Caregiver Upset
Zeitfenster: Baseline, post-intervention (approximately 8-10 weeks), and one-month follow-up.

Caregiver-rated functional dependence of the person with dementia and caregiver upset will be assessed using the Caregiver Assessment of Function and Upset (CAFU), a 15-item measure covering 8 instrumental and 7 basic activities of daily living. For each activity, the caregiver rates the level of assistance needed on a 7-point scale, which is reverse-coded for analysis so that 1 indicates complete independence and 7 indicates total assistance. Mean dependence scores are calculated separately for instrumental and basic activities (range 1 to 7), with higher scores indicating greater dependence. For each activity in which assistance is provided, the caregiver rates their upset from 0 (not at all) to 4 (extremely). Total upset scores range from 0 to 32 for instrumental activities and from 0 to 28 for basic activities, with higher scores indicating greater upset.

Baseline, post-intervention (approximately 8-10 weeks), and one-month follow-up.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Studienstuhl: Anna Ramon Aribau, PhD, University of Vic - Central University of Catalonia
  • Studienstuhl: José Antonio Merchán Baeza, PhD, University of Vic - Central University of Catalonia
  • Hauptermittler: Aitor Piñeiro Gago, MSc, OT, University of Vic - Central University of Catalonia

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. Januar 2027

Primärer Abschluss (Geschätzt)

30. Juni 2027

Studienabschluss (Geschätzt)

31. August 2027

Studienanmeldedaten

Zuerst eingereicht

14. September 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

23. Oktober 2026

Zuerst gepostet (Tatsächlich)

30. Oktober 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

9. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

4. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

Individual de-identified participant data underlying the results reported in publications arising from this study will be shared. This includes de-identified demographic, clinical, feasibility, acceptability, and outcome measure data collected as part of the study protocol that are necessary to interpret and reproduce the published findings

IPD-Sharing-Zeitrahmen

Data will be available beginning 12 months following publication of the primary study results and will remain available for 36 months

IPD-Sharing-Zugriffskriterien

Data will be made available through the institutional repository of the University of Vic - Central University of Catalonia (UVic-UCC). Requests should be directed to aitor.pineiro@uvic.cat and must include a research proposal. Proposals will be reviewed by the study team to confirm that the request aligns with the consent provided by participants and complies with applicable data protection regulations

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren